Deans' stroke musings

Changing stroke rehab and research worldwide now.Time is Brain!Just think of all the trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 493 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It's quite disgusting that this information is not available from every stroke association and doctors group.
My back ground story is here:http://oc1dean.blogspot.com/2010/11/my-background-story_8.html

Wednesday, February 7, 2018

Is Omega-3 Pointless for Preventing Heart Disease

Ask your doctor for analysis.
https://www.medpagetoday.com/cardiology/prevention/70881?





Meta-analysis showed no significant link to coronary disease, any major vascular events

  • by Senior Associate Editor, MedPage Today
Omega-3 fatty acids have gotten a heart-healthy reputation without good evidence that they actually prevent major cardiovascular disease events, according to a meta-analysis.
Across 10 large randomized trials lasting at least 1 year, taking the supplements was not associated with significantly reduced risk of:
  • Death from coronary heart disease: rate ratio 0.93 (99% CI 0.83-1.03)
  • Nonfatal myocardial infarction: RR 0.97 (99% CI 0.87-1.08)
  • Any coronary heart disease events: RR 0.96 (95% CI 0.90-1.01)
  • Major vascular events: RR 0.97 (95% CI 0.93-1.01)

Benefits also weren't seen in subgroups with prior coronary heart disease, diabetes, elevated lipid levels, or statin use, Robert Clarke, MD, of the University of Oxford in England, and colleagues reported in JAMA Cardiology.
While the European Society of Cardiology has called a protective effect of omega-3s debatable at best, the American Heart Association has recommended use as "reasonable" for secondary prevention of coronary heart disease in patients with recent events and "might also be considered" in people with heart failure and reduced ejection fraction.
"However, the results of the present meta-analysis provide no support for the recommendations to use approximately 1 g/d of omega-3 FAs in individuals with a history of CHD for the prevention of fatal CHD, nonfatal MI, or any other vascular events," Clarke's group concluded. "The results of the ongoing trials are needed to assess if higher doses of omega-3 [fatty acids] (3-4 g/d) may have significant effects on risk of major vascular events."
The study was supported by the British Heart Foundation, British Heart Foundation Centre for Research Excellence Oxford, and Medical Research Council Clinical Trial Service Unit.
Clarke disclosed no relevant relationships with industry. Co-authors disclosed multiple relevant relationships with industry.
last updated

No comments:

Post a Comment